Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

ARWR - Arrowhead Pharmaceuticals

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, May 20, 2016.

Tags:
  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA interference mechanism that silences disease-causing genes. Its ARC-520, an RNAi-based therapeutic that is in Phase IIb clinical efficacy studies to treat chronic hepatitis B virus infection; and ARC-AAT, a novel unlocked nucleobase analog containing RNAi-based therapeutic, which is in Phase Ib clinical trial for the treatment of liver disease associated with alpha-1 antitrypsin deficiency. The company's pre-clinical stage drug candidates include ARC-521, an RNAi-based therapeutic for the treatment of chronic hepatitis B virus; ARC-F12, an RNAi-based therapeutic to treat hereditary angioedema and thromboembolic diseases; ARC-HIF2, an RNAi-based therapeutic to treat renal cell carcinoma; and ARC-LPA, an RNAi-based therapeutic for the treatment of cardiovascular diseases. It also holds patents related to Adipotide for the treatment of obesity and related metabolic disorders. The company has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company was formerly known as Arrowhead Research Corporation and changed its name to Arrowhead Pharmaceuticals, Inc. in April 2016. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    $5 support held and getting some good lift today.

    ARWR: Update on Financials for Fiscal Second Quarter Ended March 31, 2016

    Total revenue for the fiscal second quarter (ARWR) was $43,750, as compared to $43,750 for the same period last year. Revenue was primarily related to licensed technology in both periods.

    R&D expenses for fiscal 2Q16 were $10 million, as compared to $21.8 million for fiscal 2Q15, which included an acquired in-process research and development cost of $10 million related to the acquisition of Novartis’ RNAi assets.
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    $8 resistance from the Aug run still solid, but this gap up is a chance to test those levels again.
     
  4. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    704
    Likes Received:
    62
    $ARWR Long setup over $2.27 Bullish
    [​IMG]
     
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    New highs!

    This chart is solid!
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    Big move over $22
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    Break out and new 52wk highs
     
  8. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    6,833
    Likes Received:
    1,869
    I would start locking on some profits on this spike.
     
  9. shaw520

    shaw520 Member

    Joined:
    Nov 11, 2019
    Messages:
    38
    Likes Received:
    24
    Great gains,... a bit late to start now,... based on the history,.. this one is ready for a correction.
     

Share This Page